Ya-ning Huang

Dr. Ya-ning Huang

MacKay Children's Hospital
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2021 in Life
Verified
Journal Article
Open access
PDF file
CLCHI-HONE LIEN
CHI-HONE LIEN
MLMing-Dar Lee
Ming-Dar Lee
SWShun-Long Weng
Shun-Long Weng
CLChao-Hsu Lin
Chao-Hsu Lin
LLLawrence Yu-Min Liu
Lawrence Yu-Min Liu
Chien-Yu LinChien-Yu Lin
Chien-Yu Lin
Coronavirus disease 2019 (COVID-19) had caused huge health losses worldwide. Several drugs had been applied to treat patients with COVID-19, and repurposing colchicine had been proposed for its anti-inflammatory properties via several pathways. In this systematic review, we evaluated the effects of colchicine treatment. From inception to May 31, 2021, databases, including PubMed, EMbase, medRxiv, and Research Square were searched, and 11 studies were enrolled. A total of 17,205 COVID-19 patients with male predominance (62.9%) were analyzed. Patients with colchicine treatment had a significantly lower risk of mortality (odds ratio (OR): 0.57, 95% confidence interval (CI): 0.38–0.87, I2: 72%; p < 0.01) and a non-significantly lower rate of mechanical ventilation (OR: 0.67, 95%CI: 0.39–1.15). The side effects were mild and not significantly different (OR: 2.03, 95%CI: 0.51–8.09). Subgroup analysis with randomized controlled trials showed no statistically significant difference in the mortality (OR: 0.80, 95%CI: 0.44–1.46, I2: 33%; p = 0.22). In conclusion, our meta-analysis found that colchicine treatment was associated with a significantly lower risk of mortality in patients with COVID-19. However, this benefit was not observed in the subgroup analysis of randomized controlled trials. Further randomized controlled studies are required to confirm the potential benefits of colchicine treatment.

25 February 2022 in Journal of Microbiology, Immunology and Infection
Verified
Journal Article
Open access
YHYa-ning Huang
Ya-ning Huang
HCHsin Chi
Hsin Chi
NCNan-Chang Chiu
Nan-Chang Chiu
CHChing-Ying Huang
Ching-Ying Huang
SLSung-Tse Li
Sung-Tse Li
DHDaniel Tsung-Ning Huang
Daniel Tsung-Ning Huang
This study aimed to evaluate whether vitamin D supplementation can reduce the incidence of influenza and enterovirus infection in Taiwanese children. This randomized, double-blind, controlled trial included children aged two to five years between April 2018 and October 2019 from daycare centers. All the participants were randomly assigned to a vitamin D supplementation group (2000 IU/day) or placebo group for one month. The primary outcome was the incidence of influenza and enterovirus infection in the following six months, and the secondary outcome was the incidence of influenza and enterovirus infection in the children's household members. Two hundred and forty-eight children participated. The vitamin D group showed a relative risk reduction of 84% against influenza compared to the placebo group but did not reach statistical significance. Kaplan-Meier curves revealed that the placebo group had a higher probability of influenza infection than the vitamin D group (log-rank test, p = 0.055), but the incidence of enterovirus infection was similar between the two groups (p = 0.946) among children. Among children's household members, the incidence of influenza (p = 0.586) and enterovirus infection (p = 0.528) were both similar between the two groups. All children who were tested for serum 25(OH)D levels after vitamin D intervention had 25(OH)D levels above 30 ng/ml CONCLUSION: Vitamin D supplementation may have a small preventative effect against influenza infection but does not affect enterovirus infection among preschool children. A high-dose short-term vitamin D intervention might be a way to elevate children's serum vitamin D levels in the first month of starting kindergarten.

22 January 2021 in JMIR Formative Research
Verified
Journal Article
Open access
YTYu-Lin Tai
Yu-Lin Tai
HCHsin Chi
Hsin Chi
NCNan-Chang Chiu
Nan-Chang Chiu
CTCheng-Yin Tseng
Cheng-Yin Tseng
YHYa-ning Huang
Ya-ning Huang
Chien-Yu LinChien-Yu Lin
Chien-Yu Lin
Background: The COVID-19 pandemic is a severe global health crisis. Wearing a mask is a straightforward action that can be taken, but shortage of stock and equity of allocation were important issues in Taiwan. Furthermore, increased anxiety leading to the stockpiling of masks has been common during the pandemic. Objective: We aim to summarize the name-based mask rationing plan implemented in Taiwan and explore the public’s perceived anxiety about mask shortages. Methods: The government of Taiwan took action to control the supply and allocation of face masks. We summarize the timeline and important components of the mask rationing plan. A survey that aimed to investigate the overall response to the mask rationing plan was answered by 44 participants. Results: The mask rationing plan was implemented in late January 2020. Daily production capacity was increased from 2 million masks to 16 million masks in April 2020. People could buy 9 masks in 14 days by verification via their National Health Insurance card. Digital face mask availability maps were created. Moreover, the mask plan safeguarded the purchase of masks and resulted in decreased anxiety about a mask shortage (4.05 [SD 1.15] points; 72.7% [n=32] of participants answered “agree” or “strongly agree”). The majority of people felt that the mask plan was satisfactory (4.2 [SD 0.92] points; 79.5% [n=35] of participants answered “agree” or “strongly agree”). Conclusions: We found that the unique name-based mask rationing plan allowed for control of the production and supply of masks, and contributed to the appropriate allocation of masks. The mask rationing plan not only provided the public with physical protection, but also resulted in reduced anxiety about mask shortages during the pandemic.

8 September 2025 in Interactive Journal of Medical Research
Verified
Journal Article
Open access
SWShun-Long Weng
Shun-Long Weng
FHFang-Yu Hung
Fang-Yu Hung
SLSung-Tse Li
Sung-Tse Li
BLBo-Huang Liou
Bo-Huang Liou
CYChun-Yan Yeung
Chun-Yan Yeung
Chien-Yu LinChien-Yu Lin
Chien-Yu Lin
Background: Dengue fever remains the most significant vector-borne disease in Southeast Asia, imposing a substantial burden on public health systems. Global warming and increased international mobility may exacerbate the disease’s prevalence. Furthermore, the unprecedented COVID-19 pandemic may have influenced the epidemiological patterns of dengue. Objective: This study aimed to evaluate epidemiological changes in dengue incidence in Southeast Asia. Methods: We conducted a retrospective, multicountry ecological study analyzing trends in dengue incidence in 7 Southeast Asian countries from January 2000 to December 2023. Data were extracted from official World Health Organization reports and national health department databases. Countries with data that were incomplete, inconsistent, or not publicly available were excluded from the final analysis. Annual incidence rates were analyzed, and linear trends were calculated to assess long-term patterns. Results: Epidemiological data from 7 Southeast Asian countries, comprising Thailand, Singapore, Vietnam, Malaysia, the Philippines, Cambodia, and Taiwan, were analyzed across the 24-year study period. A notable nadir in dengue cases was observed coinciding with the COVID-19 pandemic. Significant increasing trends in dengue incidence were identified in Singapore, Vietnam, Malaysia, and the Philippines (slopes: 8.243, 6.513, 8.737, and 8.172; R 2 values: 0.14, 0.34, 0.345, and 0.46, respectively, all P <.05). Conclusions: Dengue fever continues to pose a significant public health challenge in Southeast Asia. Our analysis demonstrates a substantial increase in dengue cases in several countries over the study period. While a temporary decline was observed during the COVID-19 pandemic, a subsequent resurgence of cases highlights the persistent threat of dengue in the region. These findings underscore the critical need for sustained surveillance and innovative control strategies to mitigate the impact of dengue in Southeast Asia.

5 October 2024 in Journal of Infection and Public Health
Verified
Journal Article
Open access
NCNan-Chang Chiu
Nan-Chang Chiu
DHDaniel Tsung-Ning Huang
Daniel Tsung-Ning Huang
SWShun-Long Weng
Shun-Long Weng
HCHsin Chi
Hsin Chi
YTYu-Lin Tai
Yu-Lin Tai
Chien-Yu LinChien-Yu Lin
Chien-Yu Lin
The global impact of COVID-19 has prompted profound shifts in public health policies. The epidemiology of respiratory infectious disease may change in the post-covid era. This study investigates the repercussions of these policies on respiratory infectious diseases, specifically the resurgence of severe influenza and enterovirus infections in the post-COVID-19 era. Examining the period from January 2020 to December 2023, our nationwide study analyzes data from the Taiwan Centers for Disease Control and Our World in Data. Two distinct phases, containing (Week 1, 2020, to Week 43, 2022) and coexisting (Week 44, 2022, to Week 50, 2023), are scrutinized, emphasizing policy changes and their potential impact on epidemiology. Epidemiological trends reveal a decline in COVID-19 and all-cause pneumonia during the co-existing period but a notable rise in severe influenza and enterovirus infections. Interrupted time series analysis confirms the surge in severe influenza and enterovirus cases post-restriction ease. The post-COVID-19 era introduces challenges with the resurgence of traditional respiratory diseases, necessitating continuous surveillance, timely non-pharmaceutical interventions, and vaccination as crucial strategies. Vigilance and targeted measures by policymakers and healthcare providers are imperative to navigate the evolving landscape of respiratory infectious diseases in the aftermath of the pandemic.

2 February 2022 in Children
Verified
Journal Article
Open access
PDF file
YHYa-ning Huang
Ya-ning Huang
LLLu-Hang Liu
Lu-Hang Liu
JCJeng-Jung Chen
Jeng-Jung Chen
YTYu-Lin Tai
Yu-Lin Tai
YDYih-Cherng Duh
Yih-Cherng Duh
Chien-Yu LinChien-Yu Lin
Chien-Yu Lin
Kawasaki disease (KD) is a systematic inflammatory disease with multiple organ involvement. Timely diagnosis and prompt management are essential for successful treatment. KD, with an atypical presentation, remains a diagnostic challenge for physicians. We report a five-year-old boy who presented with appendicitis. An appendectomy was performed; however, his fever persisted. The boy was diagnosed with KD and intravenous immunoglobulin was administered. His symptoms resolved, and he had an uneventful recovery. Furthermore, we performed a literature review with 13 cases identified in the literature. Most cases were male, and the average age was older than typical for KD. In conclusion, KD may present with abdominal complaints and appendicitis may be a rare initial presentation of KD. Multidisciplinary cooperation and high awareness are warranted for timely diagnosis, especially in older children experiencing persistent fever after an appendectomy.